Company Info
| Phone: | (617) 658-0600 |
| Year Established: | 2009 |
| Ticker: | KPTI |
| Exchange: | NASDAQ |
Contacts
| Primary: | Richard Paulson, MBA, PhD President & CEO |
| Other: | Stuart Poulton Chief Development Operations Officer Mike Mano, JD General Counsel Michael Mason, MBA, CPA CFO Sohanya Cheng CCO Reshma Rangwala, MD, PhD CMO Jessie Yeung Interim CFO |
Company Description
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions.
